Looking for big yield? ExxonMobil has it, but these three stocks should also be on your radar.
News & Analysis: GlaxoSmithKline
GlaxoSmithKline's troubles in China just won't go away
GlaxoSmithKline is accused in China of a massive bribery scheme.
Roland Head asks whether now is the right time to buy GlaxoSmithKline.
In this strong market, should you still buy GlaxoSmithKline?
We catch up on news from Vodafone, Tesco, and GlaxoSmithKline.
Do these three things make GlaxoSmithKline a poor investment?
Often viewed as just a boring income stock, GlaxoSmithKline offers significant growth potential.
Before you invest another penny in GlaxoSmithKline, let's look at cash flow, debt and dividends.
Examining Woodford's massive decisions on Vodafone, G4S, and AstraZeneca.